Literature DB >> 16407971

The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo.

Arames Crameri1, Elisa Biondi, Katrin Kuehnle, Dieter Lütjohann, Karin M Thelen, Simona Perga, Carlos G Dotti, Roger M Nitsch, Maria Dolores Ledesma, M Hasan Mohajeri.   

Abstract

The cholesterol-synthesizing enzyme seladin-1, encoded by the Dhcr24 gene, is a flavin adenine dinucleotide-dependent oxidoreductase and regulates responses to oncogenic and oxidative stimuli. It has a role in neuroprotection and is downregulated in affected neurons in Alzheimer's disease (AD). Here we show that seladin-1-deficient mouse brains had reduced levels of cholesterol and disorganized cholesterol-rich detergent-resistant membrane domains (DRMs). This was associated with inefficient plasminogen binding and plasmin activation, the displacement of beta-secretase (BACE) from DRMs to APP-containing membrane fractions, increased beta-cleavage of APP and high levels of Abeta peptides. In contrast, overexpression of seladin-1 increased both cholesterol and the recruitment of DRM components into DRM fractions, induced plasmin activation and reduced both BACE processing of APP and Abeta formation. These results establish a role of seladin-1 in the formation of DRMs and suggest that seladin-1-dependent cholesterol synthesis is involved in lowering Abeta levels. Pharmacological enhancement of seladin-1 activity may be a novel Abeta-lowering approach for the treatment of AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407971      PMCID: PMC1383521          DOI: 10.1038/sj.emboj.7600938

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  40 in total

1.  Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.

Authors:  K Fassbender; M Simons; C Bergmann; M Stroick; D Lutjohann; P Keller; H Runz; S Kuhl; T Bertsch; K von Bergmann; M Hennerici; K Beyreuther; T Hartmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

Review 2.  Alzheimer's disease and Abeta toxicity: from top to bottom.

Authors:  D H Small; S S Mok; J C Bornstein
Journal:  Nat Rev Neurosci       Date:  2001-08       Impact factor: 34.870

Review 3.  Link between heart disease, cholesterol, and Alzheimer's disease: a review.

Authors:  D L Sparks; T A Martin; D R Gross; J C Hunsaker
Journal:  Microsc Res Tech       Date:  2000-08-15       Impact factor: 2.769

Review 4.  Lipid rafts and signal transduction.

Authors:  K Simons; D Toomre
Journal:  Nat Rev Mol Cell Biol       Date:  2000-10       Impact factor: 94.444

5.  A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease.

Authors:  L M Refolo; M A Pappolla; J LaFrancois; B Malester; S D Schmidt; T Thomas-Bryant; G S Tint; R Wang; M Mercken; S S Petanceska; K E Duff
Journal:  Neurobiol Dis       Date:  2001-10       Impact factor: 5.996

6.  Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains.

Authors:  M D Ledesma; J S Da Silva; K Crassaerts; A Delacourte; B De Strooper; C G Dotti
Journal:  EMBO Rep       Date:  2000-12       Impact factor: 8.807

7.  A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.

Authors:  D Morgan; D M Diamond; P E Gottschall; K E Ugen; C Dickey; J Hardy; K Duff; P Jantzen; G DiCarlo; D Wilcock; K Connor; J Hatcher; C Hope; M Gordon; G W Arendash
Journal:  Nature       Date:  2000 Dec 21-28       Impact factor: 49.962

8.  A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.

Authors:  C Janus; J Pearson; J McLaurin; P M Mathews; Y Jiang; S D Schmidt; M A Chishti; P Horne; D Heslin; J French; H T Mount; R A Nixon; M Mercken; C Bergeron; P E Fraser; P St George-Hyslop; D Westaway
Journal:  Nature       Date:  2000 Dec 21-28       Impact factor: 49.962

9.  Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis.

Authors:  H R Waterham; J Koster; G J Romeijn; R C Hennekam; P Vreken; H C Andersson; D R FitzPatrick; R I Kelley; R J Wanders
Journal:  Am J Hum Genet       Date:  2001-08-22       Impact factor: 11.025

10.  The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress.

Authors:  I Greeve; I Hermans-Borgmeyer; C Brellinger; D Kasper; T Gomez-Isla; C Behl; B Levkau; R M Nitsch
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

View more
  64 in total

Review 1.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Dyslipidemia and the risk of Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

3.  Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress.

Authors:  Katrin Kuehnle; Arames Crameri; Roland E Kälin; Paola Luciani; Susanna Benvenuti; Alessandro Peri; Francesca Ratti; Monica Rodolfo; Luka Kulic; Frank L Heppner; Roger M Nitsch; M Hasan Mohajeri
Journal:  Mol Cell Biol       Date:  2007-11-05       Impact factor: 4.272

Review 4.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

5.  Seladin-1 expression is regulated by promoter methylation in adrenal cancer.

Authors:  Lisa Simi; Francesca Malentacchi; Paola Luciani; Stefania Gelmini; Cristiana Deledda; Rosaria Arvia; Massimo Mannelli; Alessandro Peri; Claudio Orlando
Journal:  BMC Cancer       Date:  2010-05-13       Impact factor: 4.430

6.  Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus.

Authors:  Afia Akram; James Schmeidler; Pavel Katsel; Patrick R Hof; Vahram Haroutunian
Journal:  Brain Res       Date:  2010-01-14       Impact factor: 3.252

7.  Signaling regulates activity of DHCR24, the final enzyme in cholesterol synthesis.

Authors:  Winnie Luu; Eser J Zerenturk; Ika Kristiana; Martin P Bucknall; Laura J Sharpe; Andrew J Brown
Journal:  J Lipid Res       Date:  2013-12-20       Impact factor: 5.922

8.  Alzheimer's disease: brain desmosterol levels.

Authors:  Thomas Wisniewski; Kia Newman; Norman B Javitt
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  Age-dependent increase in desmosterol restores DRM formation and membrane-related functions in cholesterol-free DHCR24-/- mice.

Authors:  Katrin Kuehnle; Maria D Ledesma; Lucie Kalvodova; Alicia E Smith; Arames Crameri; Fabienne Skaanes-Brunner; Karin M Thelen; Luka Kulic; Dieter Lütjohann; Frank L Heppner; Roger M Nitsch; M Hasan Mohajeri
Journal:  Neurochem Res       Date:  2008-12-25       Impact factor: 3.996

Review 10.  ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology.

Authors:  Antero Salminen; Anu Kauppinen; Tiina Suuronen; Kai Kaarniranta; Johanna Ojala
Journal:  J Neuroinflammation       Date:  2009-12-26       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.